How is CMV Monitored and Managed in Clinical Settings?
In clinical settings, monitoring CMV involves regular screenings, especially for high-risk individuals such as transplant recipients and pregnant women. Management strategies include the use of antiviral medications, although these can have their own toxicity profiles. Balancing the benefits and risks of antiviral therapy requires careful consideration of the patient's overall health and potential interactions with other medications and treatments.
